Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

US spend on MS therapies still escalating despite generics on the market

    This is a preview of subscription content, log in to check access.

    Reference

    1. Hartung DM, et al. Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis. Neurology : 15 Jan 2020. Available from: URL: http://doi.org/10.1212/WNL.0000000000008936

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    US spend on MS therapies still escalating despite generics on the market. PharmacoEcon Outcomes News 846, 30 (2020). https://doi.org/10.1007/s40274-020-6569-z

    Download citation